Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation

Magdalena Olbryt(The Maria Sklodowska-Curie National Research Institute of Oncology), Waldemar Priebe(The University of Texas MD Anderson Cancer Center)
Investigational New Drugs
April 17, 2017
Cited by 5


Related Papers